Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Situación reglamentaria de los medicamentos herbarios - Una reseña mundial
(2000; 60 páginas) [English] [French] View the PDF document
Table of Contents
View the documentAGRADECIMIENTOS
View the documentPREFACIO
Open this folder and view contentsI. INTRODUCCIÓN
Open this folder and view contentsII. SITUACIÓN REGLAMENTARIA
View the documentIII. CONCLUSIÓN
View the documentIV. REFERENCES
 

IV. REFERENCES

[1] Jayasuriya DC. A review of legislation concerning medicinal plants. 1990 Unpublished Report.

[2] Jayasuriya DC. The regulation of medicinal plants - a preliminary review of selected aspects of national legislation. Unpublished Report.

[3] Heide L. Traditionelle Arzneipflanzen in der Gesundheitsversorgung der dritten Welt-Möglichkeiten und Grenzen. Zeitschrift für Phytotherapie 1991; 12:1-8.

[4] DeSmet PAGM. Should herbal medicine-like products be licensed as medicines? British Medical Journal 1995; 310:1023-1024.

[5] Traditional Medicines and Modern Health Care. Progress report by the Director General. Geneva, World Health Organization, 31 October 1990.

[6] Guidelines for the Assessment of Herbal Medicines. Geneva, World Health Organization, 1991 (WHO/TRM/91.4).

[7] Guidelines for Formulation of National Policy on Herbal Medicines. Alexandria, WHO Office for the Eastern Mediterranean, 1994.

[8] Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicines. Manila, WHO Regional Office for the Western Pacific, 1994.

[9] Keita A. Pharmacopoeia in Mali. Situation of Research and Perspectives of Development. Lecture held at the Morris Arboretum Symposium, Philadelphia, 1921 April 1993. Unpublished.

[10] Gurib-Fakim A. Medicinal plants of Mauritius. A status paper on the on-going research activities and proposed future project with the WHO. University of Mauritius, May 1996. Unpublished.

[11] Gericke N. The Regulation and Control of Traditional Herbal Medicines. An international overview with recommendations for the development of a South African Approach. Traditional Medicines Programme at the University of Cape Town. Working draft document, December 1995. Unpublished.

[12] Felhaber T, Gericke N. TRAMED. Final Narrative Report: 1 June 1994 - 30 April 1996. Traditional Medicines Programme at the University of Cape Town, 1996. Unpublished.

[13] O'Reilly A. Report on involvement in scientific research and popular uses of medicinal plants and tramil survey in Antigua. Unpublished.

[14] Mulraine CA. Communication with WHO. Ministry of Health, St. John's, Antigua. 22 April 1996.

[15] Salvidia M, Bandoni AL. Plantas Medicinales: Antecedentes para su Normalización en Argentina. Acta Farm Bonaerense 1987; 6(3):195-206.

[16] Provincia de Buenos Aires, Ministerio de Salud y Acción Social. Reglamentación para el Registro y Comercialización de Hierbas Medicinales. Boletin Farmacéutico Bonaerense, Noviembre 1993, 11-12.

[17] Information Letter No. 726 of 13 August 1987. Health Protection Branch. Health and Welfare, Canada.

[18] Information Letter No. 771 of 5 January 1990. Health Protection Branch. Health and Welfare, Canada.

[19] Drugs Directorate Guidelines Traditional Herbal Medicines. Published by authority of the Minister of National Health and Welfare, Canada 1990.

[20] Medina Cardenas E. Medicina tradicional en los sistemas locales de salud, informe de Chile. Unidad de Medicina Tradicional y Otras Practicas Médicas Alternativas - Ministerio de Salud de Chile. Santiago: 1994.

[21] Decreto Numero 677 del 26/04/1995. Ministerio de Salud de la Republica de Colombia.

[22] Resolucion Numero 19593 del 03/08/1990. Ministerio de Salud de la Republica de Colombia.

[23] Viesca-Treviño C. Traditional Herbal Medicines around the Globe: Modern Perspectives. Mexican Traditional Medicine and its Pharmacological Resources. Proceedings of the 10th General Assembly of WFPMM, Seoul, Korea, 16-18 October 1991. Swiss Pharma 1991; 13(11a):79-81.

[24] Sotomayor U. Traditional Medicine in Nicaragua and its Integration into the Local Health Systems. Lecture held at the Morris Arboretum Symposium, Philadelphia, 19-21 April 1993.

[25] Kuipers SE, Farnsworth NR, Fong HMS, Segelman AB. Herbal Medicines - A Continuing World Trend. Presentation at the 1st World Federation of Proprietary Medicine Manufacturers Asia Pacific Regional Meeting, Jakarta. Unpublished.

[26] The Dietary Supplement Health and Education Act of 1994. Pub. L. No. 103-417 Washington.

[27] Marwick C. Growing Use of Medicinal Botanicals Forces Assessment by Drug Regulators. JAMA 1995; 273:607-609.

[28] Ministry of Health of the Sultanate of Oman. Conditions to allow import of traditional drugs, either Chinese/Indian or any other Origin (information sheet) Muscat, 1995.

[29] Regulations for Registration of Herbal preparations, Health and Supplementary Food, Cosmetics and Antiseptics that have Medicinal Claims. Kingdom of Saudi Arabia, Ministry of Health, General Directorate of Medical and Pharmaceutical Licences, Directorate of Pharmaceutical Licences.

[30] Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Official Journal of the European Communities nE 22 of 9 February 1965.

[31] Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. Official Journal of the European Communities nE L 147 of 9 June 1975.

[32] Commission Directive 91/507/EEC of 19 July 1991 modifying the Annex to Council Directive 75/318/EEC on the approximation of the laws of Member States relating to analytical, pharmacotoxicological and clinical standards and protocols in respect of the testing of medicinal products. Official Journal of the European Communities nE L. 270/32 of 26 September 1991.

[33] Council Directive 75/319/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Official Journal of the European Communities nE L 147 of 9 June 1975.

[34] Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products. Official Journal of the European Communities nE L 214 of 24 August 1993.

[35] Quality of Herbal Remedies. In: The Rules governing Medicinal Products in the European Community, Vol. III. Guidelines on the quality, safety and efficacy of medicinal products for human use. Luxembourg: Office for Official Publications of the European Communities, 1989.

[36] European Phytotelegram. Sixth issue. - August 1994.

[37] Coordinated Review of Monographs on Herbal Remedies. SPCs adopted by the CPMP at its May 1994 Meeting. European Commission, Directorate General III. Brussels, 18 May 1994.

[38] Steinhoff, B. European monographs - a scientific basis for harmonization? Z Phytotherapie Abstractband 1995: 20.

[39] Monographs on the Medicinal Use of Plant Drugs. Fascicules 1 and 2. European Scientific Cooperative on Phytotherapy 1996.

[40] Arzneimittelgesetz. Bundesgesetzblatt für die Republik Österreich Nr. 185/1983, geändert durch Bundesgesetze BGBl. Nr. 748/1988, Nr. 45/1991 und .../1993.

[41] 541. Verordnung des Bundesministers für Gesundheit und öffentlicher Dienst vom 16. Oktober 1989 betreffend Erleichterungen bei der Zulassung bestimmter Arzneispezialitäen. Bundesgesetzblatt für die Republik Österreich 1989:3641-3666.

[42] 727. Verordnung des Bundesministers für Gesundheit, Sport und Konsumentenschutz, mit der die Verordnung betreffend Erleichterungen bei der Zulassung bestimmter Arzneispezialitäten geändert wird. Bundesgesetzblatt für die Republik Österreich 1992:3912-3915.

[43] 580. Verordnung des Bundesministers für Gesundheit und öffentlicher Dienst und des Bundesministers für wirtschaftliche Angelegenheiten vom 21. November 1989 betreffend die Abgabe und Kennzeichnung bestimmter Arzneimittel im Kleinverkauf (Abgrenzungsverordnung). Bundesgesetzblatt für die Republik Österreich 1989:4049-4078.

[44] Ministère de la Santé Publique et de l'Environnement. Circulaire ministérielle du 30 novembre 1994. Directives à la constitution du dossier d'enregistrement des médicaments à base de plantes. Moniteur belge 1995:3103-9 (10 February 1995).

[45] Ministère de la Santé Publique et de l'Environnement. Circulaire ministérielle nE 367 du 22 septembre 1989. Directives à la constitution du dossier d'enregistrement des medicaments à base de plantes.

[46] Information letter of the Ministry of Health, National Drug Institute, Sofia, Bulgaria, dated 7 February 1996.

[47] Bekendtgørelse om naturlægemidler. Sundhedsministeriet. Nr. 790, 21 September 1992.

[48] NLN Regulatory Seminars 1995. Quality Assessment of Natural Remedies. NLN Publication No. 40. Nordic Council on Medicines, Uppsala, 1996.

[49] Procedure for registration of medicinal products and approval of variations to the terms of registered medicinal products, Estonia 1996.

[50] Marketing Authorization for a Herbal Remedy. Administrative regulation 9/93. National Agency for Medicines. 30 December 1993.

[51] Médicaments à base de plantes. Avis aux fabricants concernant les demandes d'autorisation de mise sur le marché. Ministère des Affaires Sociales et de la Solidarité. Bulletin officiel NE 90/22 bis. 1990.

[52] Bieldermann, BJ. Phytopharmaceuticals - The growing European market? Presentation at the ESCOP Symposium "European harmony in phytotherapy", 20 October 1990. ESCOP, 1990.

[53] Die junge Generation wendet sich den Naturheilmitteln zu. Allensbacher Berichte, Nr. 17 (1989).

[54] Der Selbstmedikationsmarkt in der Bundesrepublik Deutschland in Zahlen 1995. Bundesfachverband der Arzneimittel-Hersteller e.V. Bonn 1996.

[55] Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 1995 Stuttgart: Gustav Fischer Verlag, 1995.

[56] Gesetz über den Verkehr mit Arzneimitteln in der Fasssung des Gesetzes zur Neuordnung des Arzneimittelrechts vom 24. August 1976 (BGBl. I S. 2445, 2448), zuletzt geändert durch das Vierte Gesetz zur Anderung des Arzneimittelgesetzes vom 11. April 1990 (BGBl. I S. 717) Bundesrepublic Deutschland.

[57] Holz-Slomczyk M. Die Nachzulassung - Hintergründe und Ablauf. Bundesgesundheitsblatt 1990; 7:292-296 Bundesrepublic Deutschalnd.

[58] Naturheilmittel und Besondere Therapierichtungen. Bundesgesundheitsblatt 33:297-301.

[59] Keller K. Legal requirements for the use of phytopharmaceutical drugs in the Federal Republic of Germany. Journal of Ethnopharmacology 1991; 32:225-229.

[60] Keller K. Results of the revision of herbal drugs in the Federal Republic of Germany with a special focus on risk aspects. Zeitschrift für Phytotherapie 1992; 13:116-120.

[61] Keller K. Een Evaluatie van de Plantaardige Geneesmiddelen in Duitsland met Nadruk op Risico-Aspecten. Nederlandse Tijdschrift voor Fytotherapie 1993; 6:19-22.

[62] Keller K. Pflanzliche Arzneimittel - rechtlicher Status und offene Forschungsfragen. Forschungsmagazin der Johannes Gutenberg Universität Mainz, Sonderausgabe Naturheilkunde 1992; 59-68.

[63] Keller K. Prodotti fitotherapici: situatione attuale e sviluppi futuri in ambito CEE. Notizario Medico Farmaceutico 1994; 229-234.

[64] Keller K. Les médicaments à base de plantes en Allemagne et dans l'Union européenne (1re partie) Actualités Pharmaceutiques 1995; 329(3):64-66.

[65] Keller K. Les médicaments à base de plantes en Allemagne et dans l'Union européenne (2e partie) Actualités Pharmaceutiques 1995; 330(4):64-68.

[66] Braun R. Aufbereitung wissenschaftlichen Erkenntnismaterials durch Kommissionen. In: Schnieders B, Mecklenburg R, editors. Zulassung und Nachzulassung von Arzneimitteln. Basel: Aesopus, 1987:95-98.

[67] Address for correspondence: Bundesanzeiger Verlagsgesellschaft, Postfach 100534, 50445 Köln, Germany. A listing with titles of the monographs and the corresponding publication dates of the Bundesanzeiger is available at the Federal Institute for Drugs and Medical Devices, Seestrasse 10, 13353 Berlin, Germany.

[68] Steinhoff B. The legal situation of phytomedicines in Germany. British Journal of Phytotherapy 1993/94; 3(2):76-80.

[69] Fünftes Gesetz zur Änderung des Arzneimittelgesetzes vom 17. August 1994. (BGBl. I S. 2071) Bundesrepublic Deutschland.

[70] Bekanntmachung der Neufassung der Allgemeinen Verwaltungsvorschrift zur Anwendung der Arzneimittel Prüfrichtlinien vom 5. Mai 1995. Bundesanzeiger 1995; 47 No. 96a of 20 May 1995.

[71] 25. Bekanntmachung über die Verlängerung der Zulassungen nach NE 105 des Arzneimittelgesetzes (AMG) (Anwendungsgebiete für traditionelle Arzneimittel nach NE 109a AMG) vom 11. Juli 1995. Bundesanzeiger Nr. 141 vom 29. Juli 1995, 8306-8309.

[72] 28. Bekanntmachung über die Verlängerung der Zulassungen nach 105 des Arzneimittelgesetzes (AMG) (Anwendungsgebiete für traditionelle Arzneimittel nach 109a AMG) vom 25. August 1995. Bundesanzeiger Nr. 190 vom 10. Oktober 1995, 10975-10980.

[73] 29. Bekanntmachung über die Verlängerung der Zulassungen nach 105 des Arzneimittelgesetzes (AMG) (Anwendungsgebiete für traditionelle Arzneimittel nach 109a AMG) vom 15. September 1995. Bundesanzeiger Nr. 194 vom 14. Oktober 1995, 11058-11059.

[74] 30. Bekanntmachung über die Verlängerung der Zulassungen nach 105 des Arzneimittelgesetzes (AMG) (Anwendungsgebiete für traditionelle Arzneimittel nach 109a AMG) vom 20. November 1995. Bundesanzeiger Nr. 238 vom 19. Dezember 1995, 12662-12663.

[75] 35. Bekanntmachung über die Verlängerung der Zulassungen nach 105 des Arzneimittelgesetzes (AMG) (Anwendungsgebiete für traditionelle Arzneimittel nach 109a AMG) vom 3. April 1996. Bundesanzeiger Nr. 85 vom 7. Mai 1996, 15228-15231.

[76] Steinhoff B. New developments regarding phytomedicines in Germany. British Journal of Phytotherapy 1993/94; 3(4):190-193.

[77] Minister of Health, Providence & Social Insurance. Regulation 1 April 1994 Ankara.

[78] Association Européenne des Spécialités Pharmaceutiques Grand Public (AESGP), editor. Economic and Legal Framework for Non-Prescription Medicines in Europe. Brussels: AESGP, 1996:61-6.

[79] Medical Preparations (Licensing, Advertisement and Sale) Regulations, 1984 (S.I. No. 210 of 1984). Borderline Products. Department of Health, Dublin, April 1988.

[80] Guidelines for Application for Product Authorization of Herbal Products. National Drugs Advisory Board. Dublin: August 1985

[81] Morris JM. Communication of the Irish Medicines Board with WHO. 7 March 1996.

[82] Food Supplements & Health Foods. Report to the Minister of Health and the Minister for Agriculture, Food and Forestry. Food Safety Advisory Committee. Report No. 16. Dublin, December 1993.

[83] Prodotti a base di piante medicinali. Circolare n. 1 (N. 800.7.AG.8/254). Direzione Generale del Servizio Farmaceutico Divisione VII, Roma: 08/01/1981.

[84] Association Européenne des Spécialités Pharmaceutiques Grand Public (AESGP), editor. Economic and Legal Framework for Non-Prescription Medicines in Europe. Brussels: AESGP, 1996: 87-96.

[85] Retningslinjer for godkjenning av naturlegemidler. 21 January 1994.

[86] Ministério da Saude. Decreto-Lei n.E 353/93 de 7 de Outubro. Diário da República I série A n.E 235, 5623-5631 Lisboa.

[87] Association Européenne des Spécialités Pharmaceutiques Grand Public (AESGP), editor. Economic and Legal Framework for Non-Prescription Medicines in Europe. Brussels: AESGP, 1996: 105-109.

[88] Farinha A, Cachadinha M. Fitoterapia. Algumas considerações sobre a Legislação Portuguesa. LEF July 1994 no. 2

[89] Orden de 3 de octubre de 1973 por la que se establece el registro especial para preparados a base de especies vegetables medicinales. Ministerio de la Gobernación. BOE nE 247 de 15 de octubre de 1973 Madrid.

[90] La Ley des Medicamento, Art. 42.Ley 25/1990 Madrid.

[91] Medicinal Products Act 1992: 859.

[92] Information on Application for Authorization to market Natural Remedies. Medical Products Agency, Uppsala, June 1994

[93] Liste ABC. Grundsätze über die Abgrenzung der Rezeptpflicht der Heilmittel vom 10. Juni 1960 mit Nachträgen. Bern: Interkantonale Kontrollstelle für Heilmittel.

[94] Liste D. Richtlinien der IKS für die Verkaufsabgrenzung der Arzneimittel für Drogerien vom 25. November 1988. Bern: Interkantonale Kontrollstelle für Heilmittel.

[95] Interkantonale Vereinbarung über die Kontrolle der Heilmittel vom 3. Juni 1971. Bern: Interkantonale Kontrollstelle für Heilmittel.

[96] Règlement d'exécution de la Convention intercantonale sur le contrôle des médicaments du 25 mai 1972 (Etat au 23 novembre 1995). Bern: Interkantonale Kontrollstelle für Heilmittel.

[97] Mitteilungen der IKS. IKS Monatsbericht Bern: 1992 (6):345

[98] Richtlinien der IKS über die Arzneimittelinformation vom 25.11.1988. Anhang III "Arzneimittelinformationen für pflanzliche Heilmittel" vom 14.05.1992. Bern: Interkantonale Kontrollstelle für Heilmittel.

[99] Kombinationspräparate. In: Mitteilungen der IKS. IKS Monatsbericht 1990 (4):243.

[100] Akalin K. Communication of the Ministry of Health with WHO, Ankara 1996.

[101] Sezik E. Personal communication 13 October 1995. Publication in preparation.

[102] Requirements for the Establishment and production of Herbal Drug Manufacturing Premises. Ministerial Circular No. 2680. 17 January 1986. In: Ministerial Provisions concerning to Turkish Pharmaceuticals. Ministry of Health and Social Assistance. Ankara, 1986:31-40.

[103] Regulation concerning the Recall and the Seizure of the Pharmaceutical and Medical Preparations, Substances, Materials, Compounds and the Herbal Preparations. Official Gazette No. 19196, 15 August 1986. In: Ministerial Provisions concerning to Turkish Pharmaceuticals. Ministry of Health and Social Assistance. Ankara, 1986:121-131.

[104] Information requested for the Registration of Herbal Drugs. In: Ministerial Provisions concerning to Turkish Pharmaceuticals. Ministry of Health and Social Assistance. Ankara, 1986:82-84.

[105] Medicines Act 1968. London: HMSO, 1968.

[106] Review of Herbal Products under Medicines Act 1968 and EEC Directives. Medicines Act Information Sheet, DHSS Medicines Division, October 1985.

[107] The Medicines (Retail Sale or Supply of Herbal Remedies) Order 1977. London: HMSO, 1977 (Statutory Instrument: SI 1977 no. 2130).

[108] Medicines Control Agency. A Guide to what is a medicinal product. Medicines Act Leaflet MAL 8. London: December 1995.

[109] Rajagopalan TG. Traditional Herbal Medicines around the Globe: Modern Perspectives. The Indian Perspective. Proceedings of the 10th General Assembly of WFPMM, Seoul, Korea, 16-18 October 1991. Swiss Pharma 1991; 13(11a):63-67.

[110] Chakravarty BK. Herbal medicines. Safety and Efficacy Guidelines. The Regulatory Affairs Journal 1993; 4:699-701.

[111] Katim W. Communication of the Ministry of Health of the Republic of Indonesia, Directorate General of Drugs and Food Control, with WHO, 2 May 1996.

[112] Decree of the Minister of Health of the Republic of Indonesia No. 230 Men.Kes/IX/76 dated 17 September 1976 on the Compulsory Registration of Imported Crude Drugs.

[113] Guidelines on the Import and Distribution of Imported Crude Drugs/Licensed Traditional Drugs. Ministry of Health of the Republic of Indonesia, 2 November 1983.

[114] Decision of the Director General of Drugs and Food Control, Ministry of Health of the Republic of Indonesia, No. 4308/D/SK/V/1984 dated 23 May 1984 on the Procedure for the Registration of Imported Crude Drugs.

[115] Decree of the Minister of Health of the Republic of Indonesia No. 1147/D/SK/IV/81 dated 23 June 1977 on the Prohibition and Distribution of Traditional Drug used intravaginally as suppositories, or as eye drops.

[116] Decree of the Minister of Heath of the Republic of Indonesia No. 1516/A/81 dated 15 May 1981. Circulation letter on wine and the like and the use of ethanol in drugs and traditional drugs.

[117] Directorate General of Drugs and Food Control, Ministry of Health of the Republic of Indonesia No. 10107/D/X/83 dated 13 October 1983. Circulation letter on Traditional Drugs in Capsules/Tablets.

[118] Director General of Drugs and Food Control, Ministry of Health of the Republic of Indonesia decree No: 06605/D/SK/X/84 dated 3 October 1984.

[119] Guidelines on the Implementation of Labelling of Traditional Drugs. Ministry of Health of the Republic of Indonesia, 1985.

[120] Decree of the Minister of Health of the Republic of Indonesia No. 659/Men.Kes./SK/X/1991 dated 30 October 1991 on the Good Manufacturing Practices of Traditional Drugs and the Attachment.

[121] Traditional Drug Regulation. Directorate General of Drugs and Food Control. Ministry of Health of Republic of Indonesia. 1993.

[122] Gewali MB. Personal communication 16 November 1995.

[123] Koysooko R, Chuthaputti A. Promising practices in the Use of Medicinal Plants in Thailand. Lecture held at the Morris Arboretum Symposium, Philadelphia, 19-21 April 1993. Unpublished.

[124] Drug Act B.E. 2510 and its amendment. Bangkok, 1967.

[125] Therapeutic Goods Act 1989. What you need to know about the Regulatory Requirements for Manufacture and Supply of Medical Products in or from, Australia. Canberra: Therapeutic Goods Administration, 1993.

[126] General requirements for labels for drug products. Canberra: Commonwealth Department of Human Services and Health, 1994.

[127] WHO Western Pacific Regional Office (WPRO). Communication with WHO Geneva 16 April 1996.

[128] Wang X. Traditional Herbal Medicines around the Globe: Modern Perspectives. China: Philosophical Basis and Combining Old and New. Proceedings of the 10th General Assembly of WFPMM, Seoul, Korea, 16-18 October 1991. Swiss Pharma 1991; 13(11a):68-72.

[129] Drug Administration Law of the People's Republic of China, 20 September 1984.

[130] The approval of new pharmaceuticals (concerning the revision and the additional regulations on the sections on Chinese Traditional Medicine). Implemented on 1 September 1992. Ministry of Health of the People's Republic of China.

[131] Report of the Working Party on Chinese Medicine. Hongkong, October 1994.

[132] Bailey M. Communication of the Ministry of Health, Suva, Fiji, with WHO, 6 March 1996.

[133] Pillans P. Potential toxicity of herbal medicines. Centre for Adverse Reactions Monitoring, Dunedin.

[134] The NSW Therapeutic Medicines Information Centre. The uncertain world of "herbal" medication - a drug information viewpoint. Drug Bulletin 19, December 1993 - January 1994.

[135] Yamada Y. Traditional Herbal Medicines around the Globe: Modern Perspectives. Japanese Traditional Medicines. Proceedings of the 10th General Assembly of WFPMM, Seoul, Korea, 16-18 October 1991. Swiss Pharma 1991; 13(11a):76-78.

[136] Tsutani K. The evaluation of herbal medicines: an east Asian perspective. In: Lewith GT, Aldridge D (editors). Clinical Research Methodology for Complementary Therapies. London-Sydney-Auckland, Hodder & Stockton, 1993:365-393.

[137] Kishi T. Standardization of Oriental (Kampo) Medicine Formulations. Regulations and Practices in Japan. In: Lee IR, Yun-Choi HS, Chang I, editors. New Drug Developments from Natural Products. Seoul, Korean Society of Pharmacognosy, 1989.

[138] Traditional Mongolian Medicine. Information sheet. Ministry of Health. Mongolia, 1996.

[139] Ooi K. Communication of the Department of Health, New Zealand, with WHO, 28 March 1991.

[140] Cortes-Maramba NP. Medicinal Plants in the Philippines. Lecture held at the Morris Arboretum Symposium, Philadelphia, 19-21 April 1993. Unpublished.

[141] Chang SY, Won DH, Youm JR. Quality control and standardization of traditional drugs in Korea. In: Lee IR, Yun-Choi HS, Chang I, editors. New Drug Developments from Natural Products. Seoul, Korean Society of Pharmacognosy, 1989.

[142] Kim CY. Traditional Korean Medicine. Lecture held at the Morris Arboretum Symposium, Philadelphia, 19-21 April 1993. Unpublished.

[143] Pharmaceutical Department of the Ministry of Health of Singapore. Communication with WHO 13 March 1996.

[144] Medicinal Plants in Viet Nam. Manila, WHO Office for the Western Pacific, and Hanoi, Institute of Materia Medica, 1990.

to previous section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014